XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting principle
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting principle
Total United Natural Foods, Inc. Stockholders’ Equity
Total United Natural Foods, Inc. Stockholders’ Equity
Cumulative effect of change in accounting principle
Noncontrolling Interests
Beginning balance (in shares) at Aug. 03, 2019     53,501,000 615,000              
Beginning balance at Aug. 03, 2019 $ 1,504,305 $ (2,613) $ 535 $ (24,231) $ 530,801 $ (108,953) $ 1,108,890 $ (2,613) $ 1,507,042 $ (2,613) $ (2,737)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     424,000                
Restricted stock vestings and stock option exercises (819)   $ 4   (823)       (819)    
Share-based compensation 1,247       1,247       1,247    
Other comprehensive (loss) income (2,738)         (2,738)     (2,738)    
Distributions to noncontrolling interests (1,098)                   (1,098)
Proceeds from issuance of common stock, net (in shares)     196,000                
Proceeds from issuance of common stock, net 1,735   $ 2   1,733       1,735    
Net (loss) income (383,408)           (383,927)   (383,927)   519
Ending balance (in shares) at Nov. 02, 2019     54,121,000 615,000              
Ending balance at Nov. 02, 2019 $ 1,116,611   $ 541 $ (24,231) 532,958 (111,691) 722,350   1,119,927   (3,316)
Beginning balance (in shares) at Aug. 01, 2020 54,691,000   55,306,000 615,000              
Beginning balance at Aug. 01, 2020 $ 1,142,258 $ (9,237) $ 553 $ (24,231) 568,736 (237,946) 837,633 $ (9,237) 1,144,745 $ (9,237) (2,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     1,438,000                
Restricted stock vestings and stock option exercises (8,864)   $ 15   (8,879)       (8,864)    
Share-based compensation 12,242       12,242       12,242    
Other comprehensive (loss) income 12,224         12,224     12,224    
Distributions to noncontrolling interests (1,159)                   (1,159)
Proceeds from issuance of common stock, net (in shares)     5,000                
Proceeds from issuance of common stock, net 71       71       71    
Net (loss) income $ 324           (1,043)   (1,043)   1,367
Ending balance (in shares) at Oct. 31, 2020 56,135,000   56,749,000 615,000              
Ending balance at Oct. 31, 2020 $ 1,147,859   $ 568 $ (24,231) $ 572,170 $ (225,722) $ 827,353   $ 1,150,138   $ (2,279)